STD HomeData & StatisticsArchive

Figure L. Decreased Susceptibility to Azithromycin Among GISP Isolates, 1990-2008

 
This web page is archived for historical purposes and is no longer being updated. Newer data is available on the STD Data and Statistics page.
 

table icon
CLINIC% of isolates
19921993199419951996199719981999200020012002200320042005200620072008
ALBUQUERQUE.0.7...........2.3.0.6.
ATLANTA........0.41.50.82.85.2....
BALTIMORE.............0.7...
BIRMINGHAM..........0.30.7.1.0...
CHICAGO............1.01.8.1.10.4
CINCINNATI............0.30.7...
CLEVELAND....0.4............
DALLAS.............0.70.3..
DENVER.........0.71.3....2.8.
DETROIT.................
GREENSBORO...........1.3.....
HONOLULU.......2.0.1.3...1.11.1.3.8
KANSAS CITY....0.4..3.80.7.......0.8
LAS VEGAS...........0.31.41.00.72.7.
LOS ANGELES............0.41.0.1.2.
MIAMI.................
MINNEAPOLIS....1.7.0.4.....0.81.20.4..
NEW ORLEANS.........0.8.......
NEW YORK CITY...............0.60.8
OKLAHOMA CITY.................
ORANGE COUNTY........0.9.0.60.6..3.8..
PHILADELPHIA......0.4....0.3.0.30.3.0.4
PHOENIX.......0.4....0.3...0.8
PORTLAND..............0.61.4.
RICHMOND.................
SAN DIEGO........0.4.0.4.2.01.4.0.5.
SAN FRANCISCO........0.30.3.0.40.31.00.30.30.5
SEATTLE........0.5.0.40.4.0.70.40.5.

Decreased susceptibility to azithromycin is defined here as ≥ 2.0 µg/ml.

Top